CANTAB battery: Proposed utility in neurotoxicology

doi:10.1016/0892-0362(96)00027-X

Neurotoxicology and Teratology

Volume 18, Issue 4, July–August 1996, Pages 499-504

https://doi.org/10.1016/0892-0362(96)00027-X Get rights and content

Abstract

The CANTAB battery was developed for the assessment of cognitive deficits in humans with neurodegenerative diseases or brain damage. It consists of a series of interrelated computerized tests of memory, attention, and executive function, administered via a touch-sensitive screen. It allows a decomposition of complex tasks commonly used in clinical assessment into their cognitive components and enables the extrapolation of findings from the animal literature. Tests include versions of the Wisconsin Card-Sorting Test and the Tower of London and also the Delayed Matching-to-Sample test, widely used in monkeys for visual recognition memory. The tests are constructed in such a way that they may be given to animals (monkeys) with minimal change. The nonverbal nature of the CANTAB tests makes them largely language independent and culture free. CANTAB has been standardized on a large, predominantly elderly, population and validated in neurosurgical patients as well as in patients with basal ganglia disorders, Alzheimer's disease, depression, and schizophrenia. In addition, CANTAB has been used to evaluate: a) the therapeutic effects of dopaminergic and cholinergic medication in neurodegenerative disease; b) cognition in 5–11-year-old normal, learning-disabled, and autistic children; c) deficits in patients with HIV infection; and d) early, asymptomatic Huntington's disease. The latter illustrate its usefulness in early identification of progressive disorders. It is suggested that the battery should have particular utility across a wide range of age and intelligence in longitudinal assessment after exposure to toxicants, and allow meaningful comparison with experimental studies of toxic effects in other species.

References (33)

S.C. Baker et al.
Neural systems engaged by planning: A PET study of the Tower of London task
Neuropsychologia
(1996)
M. DiFiglia
Excitotoxic injury of the neostriatum: a model for Huntington's disease
Trends Neurosci.
(1990)
J.J. Downes et al.
Impaired extra-dimensional shift performance in medicated and unmedicated Parkinson's disease: Evidence for a specific attentional dysfunction
Neuropsychologia
(1989)
C. Hughes et al.
Evidence for executive dysfunction in autism
Neuropsychologia
(1994)
E.M. Joyce et al.
Frontal lobe function in Korsakoff and non-Korsakoff alcoholics: Planning and spatial working memory
Neuropsychologia
(1991)
D.S. Olton et al.
Spatial memory and hippocampal function
Neuropsychologia
(1979)
A.M. Owen et al.
Planning and spatial working memory following frontal lobe lesions in man
Neuropsychologia
(1990)
A.M. Owen et al.
Extra-dimensional vs. intra-dimensional set-shifting performance following frontal lobe excisions, temporal lobe excisions or amygdalo-hippocampectomy in man
Neuropsychologia
(1991)
A.M. Owen et al.
Visuospatial memory deficits at different stages of Parkinson's disease
Neuropsychologia
(1993)
A.M. Owen et al.
Visuo-spatial short-term recognition memory and learning after temporal lobe excision, frontal lobe excision or amydalohippocampectomy in man
Neuropsychologia
(1995)

B.J. Sahakian et al.

Sparing of attentional relative to mnemonic function in a subgroup of patients with dementia of the Alzheimer type

Neuropsychologia

(1990)

M.A. Abas et al.

Neuropsychological deficits and CT scan changes in elderly depressives

Psychol. Med.

(1990)

B.C. Beats et al.

Cognitive performance in tests sensitive to frontal lobe dysfunction in the elderly depressed

Psychol. Med.

(1996)

E.A. Berg

A simple objective technique for measuring flexibility in thinking

J. Gen. Psychol.

(1948)

J.T. Coull et al.

Contrasting effects of clonidine and diazepam on tests of working memory and planning

Psychopharmacology (Berlin)

(1995)

J.T. Coull et al.

The α-2 antagonist idazoxan remediates certain attentional and executive dysfunction in patients with dementia of frontal type

Psychopharmacology (Berlin)

(1996)

Cited by (137)

Effects of mammary cancer and chemotherapy on neuroimmunological markers and memory function in a preclinical mouse model
2023, Brain, Behavior, and Immunity - Health
Treatment modalities for breast cancer, including cyclophosphamide chemotherapy, have been associated with the development of cognitive decline (CRCD), which is characterized by impairments in memory, concentration, attention, and executive functions. We and others have identified a link between inflammation and decreased cognitive performance in patients with breast cancer receiving chemotherapy. In order to better understand the inflammation-associated molecular changes within the brain related to tumor alone or in combination with chemotherapy, we orthotopically implanted mouse mammary tumors (E0771) into female C57BL/6 mice and administered clinically relevant doses of cyclophosphamide and doxorubicin intravenously at weekly intervals for four weeks. We measured serum cytokines and markers of neuroinflammation at 48 h and up to one month post-treatment and tested memory using a reward-based delayed spatial alternation paradigm. We found that breast tumors and chemotherapy altered systemic inflammation and neuroinflammation. We further found that the presence of tumor and chemotherapy led to a decline in memory over time at the longest delay, when memory was the most taxed, compared to shorter delay times. These findings in a clinically relevant mouse model shed light on possible biomarkers for CRCD and add to the growing evidence that anti-inflammatory strategies have the potential to mitigate cancer- or treatment-related side effects.
Association between fluoride exposure in drinking water and cognitive deficits in children: A pilot study
2023, Neurotoxicology and Teratology
Fluoride (F) exposure in drinking water may lead to reduced cognitive function among children; however, findings largely remain inconclusive. In this pilot study, we examined associations between a range of chronic F exposures (low to high: 0.4 to 15.5 mg/L) in drinking water and cognition in school-aged children (5–14 years, n = 74) in rural Ethiopia. Fluoride exposure was determined from samples of community-based drinking water wells and urine. Cognitive performance was measured using: 1) assessments of ability to draw familiar objects (donkey, house, and person), and 2) a validated Cambridge Neuropsychological Test Automated Battery's (CANTAB) Paired Associate Learning (PAL), which examines memory and new learning and is closely associated with hippocampus function of the brain. Associations between F and cognitive outcomes were evaluated using regression analysis, adjusting for demographic, health status, and other covariates. The median (range) of water and urine F levels was 7.6 (0.4–15.5 mg/L) and 6.3 (0.5–15.7 mg/L), respectively; these measures were strongly correlated (r = 0.74), indicating that water is the primary source of F exposure. Fluoride in drinking water was negatively associated with cognitive function, measured by both drawing and CANTAB test performance. Inverse relationships were also found between F and drawing objects task scores, after adjusting for covariates (p < 0.05). Further analysis using CANTAB PAL tasks in the children confirmed that F level in drinking water was positively associated with the number of errors made by children (p < 0.01), also after adjusting for covariates (p < 0.05). This association between water F and total errors made became markedly stronger as PAL task difficulty increased. Fluoride exposure was also inversely associated with other PAL tasksthe number of patterns reached, first attempt memory score and mean errors to success. These findings provide supportive evidence that high F exposures may be associated with cognitive deficits in children. Additional well-designed studies are critically needed to establish the neurotoxicity of F in children and adults exposed to both low levels known to protect dental caries, as well as excess F levels in drinking water.
Impact of sleep deprivation on neurocognition and inflammation in rhesus macaques
2023, Brain, Behavior, and Immunity - Health
Sleep deprivation in humans is associated with both cognitive impairment and immune dysregulation. An animal model of neuropathogenesis may provide insight to understand the effects of sleep deprivation on the brain. Human neurocognition is more closely mirrored by nonhuman primates (NHP) than other animals. As such, we developed an NHP model to assess the impact of sleep deprivation on neurocognition and markers of systemic immune activation. Six male rhesus macaques underwent three rounds of sleep deprivation (48 h without sleep) at days 0, 14, and 28. We performed domain specific cognitive assessments using the Cambridge Neuropsychological Test Automated Battery (CANTAB) via a touch screen before and after 24 and 48 h of sleep deprivation. Immune activation markers were measured in the blood by multiplex assay and flow cytometry. Although we observed variability in cognitive performance between the three rounds of sleep deprivation, cognitive impairments were identified in all six animals. We noted more cognitive impairments after 48 h than after 24 h of sleep deprivation. Following 48 h of sleep deprivation, elevations in markers of immune activation in the blood were observed in most animals. The observed impairments largely normalized after sleep. The co-occurrence of systemic immune alterations and cognitive impairment establishes this model as useful for studying the impact of sleep deprivation on neurobehavior and immune perturbations in rhesus macaques.
Sex-specific association between prenatal manganese exposure and working memory in school-aged children in Mexico city: An exploratory multi-media approach
2023, Environmental Pollution
It remains unclear whether manganese (Mn) exposure affects working memory (WM) in a sexually dimorphic manner. Further, no gold standard media exists to measure Mn, suggesting a combined blood and urinary Mn index may better capture the totality of exposure. We investigated the modification effect of child sex on the influence of prenatal Mn exposure on WM in school-age children, exploring two methodological frameworks to integrate exposure estimates across multiple exposure biomarkers. Leveraging the PROGRESS birth cohort in Mexico City, children (N = 559) ages 6–8 completed the between errors and strategy measures of the CANTAB Spatial Working Memory (SWM) task. Mn levels were assayed in blood and urine of mothers during the 2nd and 3rd trimesters and in umbilical cord blood from mothers and children at delivery. Weighted quantile sum regression estimated the association of a multi-media biomarker (MMB) mixture with SWM. We applied a confirmatory factor analysis to similarly quantify a latent blood Mn burden index. We then used an adjusted linear regression to estimate the Mn burden index with SWM measures. Interaction terms were used to estimate the modification effect by child sex for all models. Results showed that the between-errors-specific MMB mixture (i.e., this model demonstrates the impact of the MMB mixture on the between-error scores.) was associated (β = 6.50, 95% CI: 0.91, 12.08) with fewer between errors for boys and more between errors for girls. The strategy-specific MMB mixture (i.e., this model demonstrates the impact of the MMB mixture on the strategy scores) was associated (β = −1.36, 95% CI: 2.55, - 0.18) with less efficient strategy performance for boys and more efficient strategy performance for girls. A higher Mn burden index was associated (β = 0.86, 95% CI: 0.00, 1.72) with more between errors in the overall sample. The vulnerability to prenatal Mn biomarkers on SWM differs in the directionality by child sex. An MMB mixture and composite index of body burden are stronger predictors than a single biomarker for Mn exposure on WM performance.
Dissection of neuronal circuits underlying sustained attention with the five-choice serial reaction time task
2023, Neuroscience and Biobehavioral Reviews
Attention deficits are common in psychiatric and neurological disorders. The transdiagnostic nature of impaired attention suggests a common set of underlying neural circuits. Yet, there are no circuit-based treatments such as non-invasive brain stimulation currently available due to the lack of sufficiently delineated network targets. Therefore, to better treat attentional deficits, a comprehensive functional dissection of neural circuits underlying attention is imperative. This can be achieved by taking advantage of preclinical animal models and well-designed behavioral assays of attention. The resulting findings in turn can be translated to the development of novel interventions with the goal of advancing them to clinical practice. Here we show that the five-choice serial reaction time task has greatly facilitated the study of the neural circuits underlying attention in a well-controlled setting. We first introduce the task and then focus on its application in preclinical studies on sustained attention, especially in the context of state-of-the-art neuronal perturbations.
Challenges and strategies for clinical trials in propionic and methylmalonic acidemias
2023, Molecular Genetics and Metabolism
Clinical trial development in rare diseases poses significant study design and methodology challenges, such as disease heterogeneity and appropriate patient selection, identification and selection of key endpoints, decisions on study duration, choice of control groups, selection of appropriate statistical analyses, and patient recruitment. Therapeutic development in organic acidemias (OAs) shares many challenges with other inborn errors of metabolism, such as incomplete understanding of natural history, heterogenous disease presentations, requirement for sensitive outcome measures and difficulties recruiting a small sample of participants. Here, we review strategies for the successful development of a clinical trial to evaluate treatment response in propionic and methylmalonic acidemias. Specifically, we discuss crucial decisions that may significantly impact success of the study, including patient selection, identification and selection of endpoints, determination of the study duration, consideration of control groups including natural history controls, and selection of appropriate statistical analyses. The significant challenges associated with designing a clinical trial in rare disease can sometimes be successfully met through strategic engagement with experts in the rare disease, seeking regulatory and biostatistical guidance, and early involvement of patients and families.

View all citing articles on Scopus

View full text

DemonstrationCANTAB battery: Proposed utility in neurotoxicology

Abstract

Neuropsychologia

Trends Neurosci.

Neuropsychologia

Neuropsychologia

Neuropsychologia

Neuropsychologia

Neuropsychologia

Neuropsychologia

Neuropsychologia

Neuropsychologia

Neuropsychologia

Neuropsychological deficits and CT scan changes in elderly depressives

Psychol. Med.

Cognitive performance in tests sensitive to frontal lobe dysfunction in the elderly depressed

Psychol. Med.

A simple objective technique for measuring flexibility in thinking

J. Gen. Psychol.

Contrasting effects of clonidine and diazepam on tests of working memory and planning

Psychopharmacology (Berlin)

The α-2 antagonist idazoxan remediates certain attentional and executive dysfunction in patients with dementia of frontal type

Psychopharmacology (Berlin)

Demonstration
CANTAB battery: Proposed utility in neurotoxicology